Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
GLP-1 medications require ongoing use to prevent regaining up to two-thirds of the lost weight
TRIUMPH-4 represents Eli Lilly's first successful Phase 3 trial for Retatrutide, moving beyond the promising Phase 2 results from 2023 that showed 24% weight loss
Questions and Answers: Benzyl alcohol in the context of revision of the guideline on excipients in the label and package leaflet
SGLT-2i=sodium-glucose cotransporter-2 inhibitor
Antioxidant potential of probiotics and postbiotics: a biotechnological approach to improving their stability
US$ 25.64
US$ 24.80
US$ 24.74
US$ 27.05
